These risks are higher in older adults where age-related muscle loss, known as sarcopenia, is already a factor
What this trial could tell us If results are positive, we would expect to see statistically significant differences between the resM group and placebo group in body weight, BMI, and relevant biomarkers like fasting glucose, insulin, and possibly GLP-1 levels
Our results identified specific metabolites that could discriminate OC from BOT and control subjects in various samples
Label adhesion: Labels on counterfeits frequently lift at the edges or appear glued rather than heat-sealed
Systemic PUVA versus narrowband UVB in the treatment of vitiligo: a randomized controlled study
This has led to a surge in gray market research chemicals